S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - A multivariate study of 770 patients

Cytopathology

Volumn 19, Issue 5, 2008, Pages 294-302

  Gazic, B ^b   Pizem, J ^a   Bracko, M ^b   Cufer, T ^b   Borstnar, S ^b   Pohar Marinsek, Z ^b   Us Krasovec, M ^b  

^a INSTITUTE OF PATHOLOGY   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Breast cancer; Cytopathology; Fine needle aspirates; Flow cytometry; Multivariate analysis; S phase fraction; Survival

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOMETRY; DISEASE FREE SURVIVAL; DNA DETERMINATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL;

BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; S PHASE; SURVIVAL ANALYSIS;

EID: 51749119468     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2007.00528.x     Document Type: Article

References (28)

1. Mirza AN, Mirza NQ, Vlastos G, Singletary SE. Prognostic factors in node-negative breast cancer. A review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 2002 235 : 10 26.
2. Wenger CR, Clark GM. S-phase fraction and breast cancer: a decade of experience. Breast Cancer Res Treat 1998 51 : 255 65.
3. Fitzgibbons PL, Page DL, Weaver D et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000 124 : 966 78.
4. Mandard AM, Denoux Y, Herlin P et al. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial. Cancer 2000 89 : 1748 57.
5. Michels J-J, Duigou F, Marnay J. Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity. Breast Cancer Res Treat 2000 62 : 117 26.
6. Otto F. DAPI staining of fixed cells for high resolution flow cytometry of nuclear DNA. In : Methods in Cell Biology. Darzynkiewicz Z, Crissman HA (eds). San Diego, CA : Academic Press 1990 : pp. 105 10.
7. Pogacnik A, Us-Krasovec M, Bracko M. Preparation of fine needle aspiration biopsy samples for flow cytometric analysis. Anal Quant Cytol Histol 1993 15 : 298 302.
8. Pinto AE, Mendonca E, Andre S, Nobrega SD, Soares J. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer. Anal Quant Cytol Histol 2002 24 : 345 54.
9. Spyratos F, Briffod M. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures. Mod Pathol 1997 10 : 556 63.
10. Vielh P, Carton M, Padoy E et al. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma. Cancer (Cancer Cytopathol) 2005 105 : 476 82.
11. Remvikos Y, Vielh P, Padoy E, Benyahia B, Voillemont N, Magdelenat H. Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation. Br J Cancer 1991 64 : 501 7.
12. Tavassoli FA, Devilee P (eds). World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon : IARC Press 2003.
13. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology 1991 19 : 403 10.
14. Frkovic-Grazio S, Bracko M. Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. J Clin Pathol 2002 55 : 88 92.
15. Michels J-J, Marnay J, Plancoulaine B, Chasle J. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns. Cytometry 2004 59B : 32 9.
16. Chassevent A, Jourdan ML, Romain S et al. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Clin Cancer Res 2001 7 : 909 17.
17. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma. Importance of prognostic markers of the primary tumor. Cancer 2003 97 : 545 53.
18. Pinto AE, Andre S, Mendonca E, Silva G, Soares J. Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients. Int J Biol Markers 2003 18 : 7 12.
19. Gazic B, Pizem J, Us-Krasovec M. The dilution effect of non-tumor cells on flow-cytometric DNA S-phase fraction in breast fine-needle aspirates. Anal Quant Cytol Histol 2005 27 : 277 83.
20. Bracko M, Us-Krasovec M, Cufer T, Lamovec J, Zidar A, Goehde W. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma. Anal Quant Cytol Histol 2001 23 : 56 66.
21. Wingren S, Stal O, Nordenskjold B. Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. Br J Cancer 1994 69 : 546 9.
22. Zarbo RJ, Visscher DW, Crissman JD. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol 1989 11 : 391 402.
23. Kute TE, Russell GB, Zbieranski N et al. Prognostic markers in node negative breast cancer: a prospective study. Cytometry 2004 59B : 24 31.
24. Bagwell CB, Clark GM, Spyratos F et al. Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node negative breast cancer specimens. Cytometry 2001 46 : 121 35.
25. Bagwell CB. DNA histogram analysis for node negative breast cancer. Cytometry 2004 58A : 76 8.
26. Bryant J, Fischer B, Gündüz N et al. S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer. Breast Cancer Res Treat 1998 51 : 239 53.
27. Harbeck N, Dettmar P, Thomssen C et al. Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up. Br J Cancer 1999 80 : 419 26.
28. Massod S. Assessment of prognostic factors in breast fine-needle aspirates. Am J Clin Pathol 2000 113 (Suppl. 1 84 96.